Accessibility Menu
Viatris logo

Viatris

(NASDAQ) VTRS

Current Price$16.17
Market Cap$19.17B
Since IPO (1984)+3,817%
5 Year+38%
1 Year+86%
1 Month+0%

Viatris Financials at a Glance

Market Cap

$19.17B

Revenue (TTM)

$14.56B

Net Income (TTM)

-$296.50M

EPS (TTM)

-$0.26

P/E Ratio

-63.05

Dividend

$0.48

Beta (Volatility)

0.80 (Low)

Price

$16.17

Volume

1,384,096.093

Open

$16.36

Previous Close

$16.33

Daily Range

$16.11 - $16.52

52-Week Range

$8.63 - $17.53

Estimated Earnings Date

Aug 6, 2026

VTRS: Motley Fool Moneyball Superscore

44

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Viatris

Industry

Pharmaceuticals

Employees

30,000

CEO

Scott Andrew Smith

Headquarters

Canonsburg, PA 15317, US

VTRS Financials

Key Financial Metrics (TTM)

Gross Margin

34.40%

Operating Margin

0.96%

Net Income Margin

-2.04%

Return on Equity

-1.97%

Return on Capital

-9.05%

Return on Assets

-0.80%

Earnings Yield

-1.59%

Dividend Yield

2.94%

Payout Ratio

-1.88%

Stock Overview

Market Cap

$19.17B

Shares Outstanding

1.17B

Volume

1.38M

Avg. Volume

10.75M

Financials (TTM)

Gross Profit

$5.01B

Operating Income

$139.40M

EBITDA

$2.57B

Operating Cash Flow

$2.17B

Capital Expenditure

-$459.00M

Free Cash Flow

$1.71B

Cash & ST Invst.

$1.80B

Total Debt

$14.34B

Viatris Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q1 2026YOY CHG

Revenue

$3.52B

+8.1%

Gross Profit

$1.16B

-0.3%

Gross Margin

32.90%

N/A

Market Cap

$19.17B

N/A

Market Cap/Employee

$598.94K

N/A

Employees

32,000

N/A

Net Income

$176.40M

+105.8%

EBITDA

$643.90M

+127.8%

Quarterly Fundamentals

Name
Q1 2026YOY CHG

Total Cash

$1.80B

+80.0%

Total Debt

$14.34B

-0.8%

Accounts Receivable

$3.08B

-9.2%

Inventory

$3.93B

-4.1%

Long Term Debt

$12.41B

-13.5%

Short Term Debt

$1.93B

+1758.6%

Return on Assets

-0.80%

N/A

Return on Invested Capital

0.46%

N/A

Free Cash Flow

$348.40M

-24.1%

Operating Cash Flow

$388.30M

-27.5%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
EXASExact Sciences Corporation
$104.91+0.00%
NBIXNeurocrine Biosciences, Inc.
$170.31+1.06%
BBIOBridgeBio Pharma, Inc.
$71.95+2.43%
ROIVRoivant Sciences Ltd.
$34.21+0.41%

Trending Stocks

Symbol / CompanyPricePrice Chg
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$12.66+0.09%
MUMicron Technology
$1,060.30-0.06%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$5.61-0.01%
AALAmerican Airlines Group
$17.96+0.01%

Questions About VTRS

What is the current price of Viatris?

Viatris is trading at $16.25 per share.

What is the 52-week range for Viatris?

Over the past 52 weeks, Viatris has traded between $8.63 and $17.53.

How much debt does Viatris have?

As of the most recent reporting period, Viatris reported total debt of $14.61B.

How much cash does Viatris have on hand?

Viatris reported $1.81B in cash and cash equivalents in its most recent financial results.

What is Viatris’s dividend yield?

Viatris currently has a dividend yield of 2.94%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.